How soon should I follow up after a networking event?

Within two days. After that you're a vague name from a badge. Mention where you met and the topic, send anything you promised, and keep the ask optional. If they wanted a pitch, they would have asked. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Is it okay to send this introduction on LinkedIn instead of email?

Yes if this sales VP is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals introduction?

Don't use consumer-startup slang. It's a credibility leak. Telling them how to sell. They've heard it. Don't dump a calendar link as the first follow-up unless they asked. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Can I use aggressive sales language in pharma outreach?

No. Unapproved claims, off-label hints, and fake urgency can create real problems. Be operational: timelines, review status, access, meeting logistics. Save clinical discussion for approved materials and the right role. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Pharmaceuticals · Sales VP · After Networking

Introduction for Pharmaceuticals Sales VP: After Networking

Q: How should a introduction to a Pharmaceuticals Sales VP change for after networking?

Human. If you pitch immediately, you retroactively made the chat feel extractive. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. The sales VP is guarding quota, forecast credibility, and rep time, so the ask should stay at "a 15-minute look at one metric, not a platform tour."

A introduction email for a Pharmaceuticals Sales VP (after networking) is a short message that reopens the thread without making them do extra work. An introduction email explains who you are, why this person should care, and what a good next step looks like, without making them do the homework. In this setting, that means speaking to follow-up that ignores

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this introduction work for a Pharmaceuticals Sales VP?

Make it easy to decline.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a sales VP actually reads: 70 to 90 words. Lead with the outcome.
Remind them of the exact topic you both lingered on.
Lead with the overlap, not your résumé.

When should I send this to a Pharmaceuticals Sales VP?

If a mutual offered the intro, send it while their permission is fresh. Within 24 to 48 hours while they still remember your face or handle. For this combo, treat "1-2 days" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a sales VP, 70 to 90 words. Lead with the outcome. If they named a board week or a freeze, believe it and leave a reopen date.

What this Sales VP actually cares about

A sales VP in Pharmaceuticals is protecting quota, forecast credibility, and rep time. They think in pipeline, ramp, and forecast risk. If you can't map your email to a number they already report, it feels like a hobby. The hook that earns a look is a stage in the funnel that's leaking, a slow follow-up SLA, or a ramp problem. The ask should stay at this size: a 15-minute look at one metric, not a platform tour. Delete trigger: Telling them how to sell. They've heard it. They protect quota, forecast credibility, and rep time, so keep the ask at "a 15-minute look at one metric, not a platform tour."

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. A thread that ignores follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick reads like every other vendor bump.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone crisp and commercial.
Don't attach your pitch deck to an intro.
Time it for 1-2 days. Within 24 to 48 hours while they still remember your face or handle.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after networking note?

Giant bios make intros feel like homework.
Don't dump a calendar link as the first follow-up unless they asked.
Don't use consumer-startup slang. It's a credibility leak.
Telling them how to sell. They've heard it.

How does this after networking scenario compare?

Dimension	For this template
Best send window	1-2 days
Ideal length	70 to 90 words. Lead with the outcome.
Primary ask	a 15-minute look at one metric, not a platform tour
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Crisp and commercial. They can handle a direct ask.
Unlike cold email	You have a shared moment. Use it. Writing like a stranger wastes the introduction.
Unlike introduction	You already met. Don't re-introduce your whole bio.

What should I copy and send?

Copy-ready template

Subject

Pharmaceuticals note on follow-up that ignores MLR, off-label risk,

Body

Hi [First Name],

I'm reaching out because [specific overlap], not because I collect new LinkedIn contacts.

I'm writing because a label update, a launch window, or a congress. Happy to send a 5-line brief before any call so you know what you'd be walking into.

Remind them of the exact topic you both lingered on.

If you'd rather I talk to [other role], I can do that.

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Use one sentence for who you help and one sentence for why now. Skip the origin story. If a mutual is involved, put their name near the top so the email has a human reason to exist. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Related templates

Want a custom draft instead? Try the email generator.